Head-to-head · Value Score
Alan Meds vs Henry Meds
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Henry Meds a 78. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#5 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameHenry Meds
#23 · Grade B- · Fair Price
Est. first month
$249/mo
Save ~82% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 78 — an est. $99/mo first month, with no teaser step-up baked in. Henry Meds isn't out of it: People who want a simple, well-known flat-fee program and will pay a premium for it.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | Henry Meds |
|---|---|---|
| Value Score | 90 (A) | 78 (B-) |
| Est. first month | $99/mo | $249/mo |
| Save vs brand-name | ~93% | ~82% |
| Semaglutide | $99/mo | $249/mo |
| Tirzepatide | $145/mo | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
Henry Meds
The flat-fee pioneer: honest, no step-ups — just priced at the higher end of the market now.
Why it's a deal
- Simple flat-fee model with no teaser step-ups
- Well-established brand
- Both molecules
The fine print
- Higher pricing than most newer entrants
- Compounded only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.